CorMedix Inc. (CRMD) financial statements and ratios from SEC XBRL: revenue $311.71M (TTM), net margin 52.3%, revenue growth 156.5% YoY, P/E 3.4. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $311.71M |
| Net Margin | 52.3% |
| Revenue Growth (YoY) | 156.5% |
| EPS Growth (YoY) | 13.8% |
| FCF Growth (YoY) | 185.9% |
| P/E Ratio | 3.4 |
| EV / EBITDA | 1.6 |
| Price / Book | 1.39 |
| Price / Sales | 1.38 |
| FCF Yield | 39.2% |
| DCF Value (model) | $88.63 |
| DCF Upside vs Price | 982.2% |
| Altman Z-Score | 1.88 (grey) |
| Sector P/E (Healthcare) | 21.7 |
CRMD overview · CRMD earnings · CRMD KPIs · CRMD investor relations · CRMD ownership · CRMD peers · CRMD filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.